Starling Oncology, Inc.
STLN
NASDAQ·Healthcare·Medical - Care Facilities·Mkt cap $592.9M
$5.93
▼ -0.67%
P/E
-19.77
Mkt Cap
$592.9M
52-Wk Range
$2.32–$7.05
52-Week Range
$2.32 - $7.05
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 2.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta 0.4).
Growth
Moderate growth ahead
Value
Deep value opportunity - significant discount to sector peers
Momentum
Stable
+2.2% over 3m
Quality
Thin
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying STLN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
AUG 6, 2026
Reported EPS of -$0.08 vs -$0.06 consensus (-25.0% surprise). Revenue of $161.3M vs $155.7M expected (+3.6%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-25.0%
Revenue trend · last 4Q
—
—
—
—
Q3 25
Q4 25
Q1 26
Q2 26
$136.6M
$142.0M
$147.4M
$161.3M
Margins · last 4Q
Profit
-6.1%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: B. Riley · Aug 7, 2026
vs Industry
How STLN stacks vs Medical - Care Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.